Diabetes

Diabetes drugs known as GLP-1 receptor agonists, such as exenatide (Byetta), are a promising and safe treatment for a rare form of obesity. Read More

Vanderbilt researchers have identified a signaling pathway that promotes kidney fibrosis in patients with diabetes — and that could be targeted with an existing approved medication. Read More

One in nine American adults has diabetes, and one in three has pre-diabetes. Prevention and early intervention can decrease the risk of complications down the road. Read More

Research by Vanderbilt history professor Arleen Tuchman on the cultural history of diabetes offers important lessons for other public health challenges, including COVID-19. Read More

Vanderbilt cell biologists are defining the factors that help beta cells in the pancreas stay healthy, secrete insulin and prevent diabetes initiation and progression. Read More

Variation in the levels of hormones called natriuretic peptides may contribute to racial differences in susceptibility to diabetes, suggesting that this hormone system may be a target for reducing risk of the disease. Read More

Post-transplantation diabetes mellitus (PTDM), a common complication of immunosuppressive drugs that are given to prevent transplant rejection, may be reversible and at least partially preventable, researchers at VUMC report. Read More

Shichun Bao, associate professor of medicine and the Diabetes Technology Program leader in the Division of Endocrinology at the Eskind Diabetes Clinic, shares information on the amazing technological advances in diabetes treatment and blood sugar management. Read More

The identification of a protein important for insulin synthesis may hold clues for understanding the pathogenesis of diabetes. Read More

An observational study using medical record information from nearly 50,000 U.S. military veterans sheds new light on which drugs are best for patients with Type 2 diabetes and one of its common complications, kidney disease. Read More

The purpose of this study is to measure a metabolite called α-aminoadipic acid (2-AAA) in blood. Different amounts of 2-AAA in the body may alter the risk of developing diabetes Read More

Researchers have made a paradigm-shifting discovery that could lead to new treatments, better health and longer life for patients with Type 1 diabetes. Read More

Microtubules, part of the cell's cytoskeleton, regulate the secretion of insulin, suggesting that they may be a new target for treating diabetes. Read More

The Vanderbilt Diabetes Center, the Vanderbilt Diabetes Research and Training Center (DRTC), and the Vanderbilt Center for Diabetes Translation Research (CDTR) announce the availability of Pilot and Feasibility Grants in diabetes or obesity-related research. Read More

Individuals with Type 1 diabetes between the ages of 18-28 are invited to give feedback on the challenges of transitioning from pediatric to adult care providers. Read More

An unexpected finding by Rachana Haliyur during the cellular analysis of human pancreatic tissue has revealed new information about a rare type of diabetes and underscores the importance of genetic testing for some individuals diagnosed with type 1 diabetes. Read More

Brian Engelhardt is studying why as many as 50 percent of stem cell transplant recipients develop diabetes. Read More

Employees are invited to February information sessions to learn more about the National Diabetes Prevention Program, available to faculty, staff or spouses with prediabetes or a history of gestational diabetes. Read More

Researchers at Vanderbilt University Medical Center have identified a biomarker for insulin-producing beta cells. Their finding could lead to improved ways to study and treat diabetes. Read More

A recent study led by Xiao-Ou Shu and colleagues found that green tea drinking was associated with increased risk of type 2 diabetes in Chinese adults, possibly due to the use of pesticides on tea plants--though the researchers call for further study of the exact mechanism. Read More